Matouschek E, Huber R
Urologe A. 1979 Jul;18(4):211-4.
Statistic analysis of data from 209 calcium oxalate stone patients and 42 stone-free patients pertinent to the concentration and excretion of uric acid in urine and of uric acid levels in the serum yielded no significant difference between the two groups. Only 17% of the calcium oxalate stone patients suffered from hyperuricuria and hyperuricemia was found only in 15% of these patients. Based on these findings, our in-vitro experiments as to the influence of uric acid on calcium oxalate stone formation yielded the following results: firstly, precipitates in urine form only at uric acid concentrations which in-vivo are rate exceptions humans, and secondly, the precipitates at pH 5.5--6.0 always contain uric acid, and a precipitation of calcium oxalate only is never observed. From the experiments one has to conclude that there exists no "salting-out effect" of uric acid on calcium oxalate in urine but rather that precipitate formation reflects the individual solution- and crystallization characteristics of the precipitating compounds.
对209例草酸钙结石患者和42例无结石患者尿液中尿酸浓度和排泄量以及血清中尿酸水平的数据进行统计分析,结果显示两组之间无显著差异。仅17%的草酸钙结石患者患有高尿酸尿症,而这些患者中仅有15%存在高尿酸血症。基于这些发现,我们关于尿酸对草酸钙结石形成影响的体外实验得出了以下结果:首先,尿液中的沉淀物仅在尿酸浓度处于体内人类罕见水平时形成;其次,在pH值为5.5 - 6.0时形成的沉淀物总是含有尿酸,从未观察到仅草酸钙沉淀的情况。从实验中可以得出结论,尿酸对尿液中草酸钙不存在“盐析效应”,而是沉淀物的形成反映了沉淀化合物各自的溶解和结晶特性。